- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x NA: SODIUM ION(Non-functional Binders)
NA.4: 6 residues within 4Å:- Chain A: N.148, I.149, H.233, P.348, T.351
- Ligands: CL.3
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:H.233
NA.6: 5 residues within 4Å:- Chain A: L.147, W.150, A.463, S.466, S.467
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.466, A:S.467
NA.23: 6 residues within 4Å:- Chain B: N.148, I.149, H.233, P.348, T.351
- Ligands: CL.22
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:T.351
NA.25: 5 residues within 4Å:- Chain B: L.147, W.150, A.463, S.466, S.467
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:W.150, B:S.467
- 6 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.7: 8 residues within 4Å:- Chain A: T.179, N.565, W.567, A.568, F.571
- Ligands: Y01.8, Y01.9, LPE.10
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:T.179, A:N.565, A:W.567, A:A.568, A:F.571, A:F.571, A:F.571, A:F.571
Y01.8: 12 residues within 4Å:- Chain A: L.169, I.172, L.176, P.330, W.332, F.339, F.340, F.571, I.575
- Ligands: Y01.7, LPE.10, LPE.12
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:L.169, A:L.176, A:P.330, A:F.339, A:F.339, A:F.339, A:F.339, A:F.340, A:F.340, A:F.571, A:I.575
Y01.9: 8 residues within 4Å:- Chain A: W.567, L.570, F.571, I.574, I.575
- Ligands: Y01.7, LPE.12, POV.14
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:W.567, A:W.567, A:W.567, A:L.570, A:F.571, A:F.571, A:I.574, A:I.574, A:I.575
Y01.26: 7 residues within 4Å:- Chain B: T.179, I.183, N.565, W.567, F.571
- Ligands: Y01.28, LPE.29
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:T.179, B:I.183, B:F.571, B:F.571
Y01.27: 11 residues within 4Å:- Chain B: L.169, I.172, L.176, P.330, W.332, F.339, F.340, F.571, I.575
- Ligands: LPE.29, LPE.31
15 PLIP interactions:15 interactions with chain B- Hydrophobic interactions: B:L.169, B:I.172, B:L.176, B:L.176, B:P.330, B:F.339, B:F.339, B:F.339, B:F.339, B:F.339, B:F.339, B:F.340, B:F.340, B:F.571, B:I.575
Y01.28: 7 residues within 4Å:- Chain B: W.567, F.571, I.574, I.575
- Ligands: Y01.26, LPE.31, POV.33
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:W.567, B:W.567, B:W.567, B:W.567, B:F.571, B:F.571, B:F.571, B:I.574, B:I.574, B:I.575
- 8 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
LPE.10: 8 residues within 4Å:- Chain A: T.179, S.182, L.186, Q.562, Y.563, N.565
- Ligands: Y01.7, Y01.8
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.186
- Hydrogen bonds: A:Q.562
LPE.11: 16 residues within 4Å:- Chain A: V.178, T.193, A.367, I.368, P.371, K.372, L.375, M.376, I.378, F.379, T.382, I.383, S.560, F.561, Q.562, Y.563
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:V.178, A:L.375, A:L.375, A:L.375, A:I.378, A:F.379, A:F.379, A:T.382, A:I.383
LPE.12: 10 residues within 4Å:- Chain A: D.336, T.338, F.340, I.574, L.582, L.583
- Chain B: W.585
- Ligands: Y01.8, Y01.9, POV.21
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.574, A:L.582
- Hydrogen bonds: A:T.338, A:T.338, A:G.341
LPE.13: 11 residues within 4Å:- Chain A: W.137, V.138, M.142, M.146, F.289, F.296, L.300, W.380, S.384, I.388
- Ligands: POV.15
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.289, A:F.296, A:L.300, A:W.380, A:I.388
LPE.29: 8 residues within 4Å:- Chain B: L.175, T.179, S.182, Q.562, Y.563, N.565
- Ligands: Y01.26, Y01.27
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:L.175
- Hydrogen bonds: B:Q.562
LPE.30: 10 residues within 4Å:- Chain B: V.178, K.372, L.375, M.376, F.379, T.382, I.383, L.386, F.561, Q.562
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:V.178, B:L.375, B:F.379, B:T.382, B:I.383, B:L.386
LPE.31: 7 residues within 4Å:- Chain B: T.338, F.340, L.582
- Ligands: POV.17, Y01.27, Y01.28, POV.33
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:F.340, B:L.582
LPE.32: 8 residues within 4Å:- Chain B: V.138, M.142, M.146, L.300, W.380, S.384, A.387, I.388
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:L.300, B:L.300, B:W.380, B:W.380, B:A.387, B:I.388
- 9 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.14: 21 residues within 4Å:- Chain A: C.537, A.540, L.541, F.544, I.551, K.566, W.567, L.570, A.573, I.574, V.577, I.592
- Chain B: G.593, L.596, F.597, L.600, Y.601, Y.604
- Ligands: Y01.9, POV.18, POV.21
15 PLIP interactions:12 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:A.540, A:L.541, A:F.544, A:F.544, A:F.544, A:F.544, A:W.567, A:L.570, A:A.573, A:I.574, A:I.592, B:L.596, B:F.597, B:F.597
- Salt bridges: A:K.566
POV.15: 11 residues within 4Å:- Chain A: W.171, Y.319, R.320, A.321, F.324, I.383, A.387, A.390, T.391, S.394
- Ligands: LPE.13
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:W.171, A:Y.319, A:Y.319, A:Y.319, A:F.324, A:A.387, A:A.390, A:A.390
- Hydrogen bonds: A:A.321
POV.16: 13 residues within 4Å:- Chain A: L.220, I.221, F.224, R.260, A.517, F.518, I.520, I.521, T.526, F.534, W.586, I.590, V.594
18 PLIP interactions:18 interactions with chain A- Hydrophobic interactions: A:L.220, A:I.221, A:F.224, A:F.224, A:F.224, A:F.224, A:F.224, A:F.518, A:F.518, A:I.520, A:I.521, A:F.534, A:F.534, A:W.586, A:W.586, A:I.590, A:V.594
- Hydrogen bonds: A:R.260
POV.17: 11 residues within 4Å:- Chain A: T.584, W.585, W.586, L.589, I.590, L.596, F.597
- Chain B: V.577
- Ligands: POV.18, LPE.31, POV.33
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:W.585, A:W.586, A:W.586, A:W.586, A:L.589, A:L.589, A:I.590, A:I.590, A:I.590, A:L.596, A:F.597, B:V.577
POV.18: 21 residues within 4Å:- Chain A: E.213, F.544, H.548, T.552, I.592, V.595, L.596, L.599, L.600
- Chain B: E.213, F.544, H.548, I.592, L.596, L.599, L.600, I.603, Y.604
- Ligands: POV.14, POV.17, POV.21
16 PLIP interactions:10 interactions with chain A, 6 interactions with chain B- Hydrophobic interactions: A:F.544, A:I.592, A:V.595, A:L.596, A:L.596, A:L.596, A:L.599, A:L.600, B:F.544, B:I.592, B:L.596, B:L.599, B:L.599, B:I.603
- Salt bridges: A:H.548, A:H.548
POV.20: 10 residues within 4Å:- Chain B: L.220, I.221, F.224, A.517, F.518, I.521, T.526, F.534, W.586, V.594
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:L.220, B:I.221, B:F.224, B:F.224, B:F.224, B:F.224, B:F.518, B:F.518, B:I.521, B:F.534, B:V.594
POV.21: 10 residues within 4Å:- Chain A: V.577
- Chain B: W.585, W.586, L.589, I.590, V.594, L.596
- Ligands: LPE.12, POV.14, POV.18
10 PLIP interactions:1 interactions with chain A, 9 interactions with chain B- Hydrophobic interactions: A:V.577, B:W.586, B:W.586, B:W.586, B:W.586, B:L.589, B:I.590, B:I.590, B:V.594, B:L.596
POV.33: 22 residues within 4Å:- Chain A: G.593, L.596, F.597, L.600, Y.601, Y.604
- Chain B: C.537, A.540, L.541, F.544, F.547, I.551, K.566, W.567, L.570, I.574, V.577, I.592, V.595
- Ligands: POV.17, Y01.28, LPE.31
15 PLIP interactions:4 interactions with chain A, 11 interactions with chain B- Hydrophobic interactions: A:L.596, A:F.597, A:L.600, A:Y.604, B:A.540, B:L.541, B:F.544, B:F.544, B:F.544, B:F.547, B:W.567, B:L.570, B:I.574, B:I.592, B:V.595
POV.34: 11 residues within 4Å:- Chain B: W.171, L.300, Y.319, R.320, A.321, D.322, F.324, I.383, L.386, A.390, S.394
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:W.171, B:W.171, B:L.300, B:Y.319, B:Y.319, B:F.324, B:I.383, B:L.386, B:A.390
- Hydrogen bonds: B:A.321
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nan, J. et al., Cryo-EM structure of the human sodium-chloride cotransporter NCC. Sci Adv (2022)
- Release Date
- 2022-11-23
- Peptides
- Solute carrier family 12 member 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x NA: SODIUM ION(Non-functional Binders)
- 6 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 8 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 9 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nan, J. et al., Cryo-EM structure of the human sodium-chloride cotransporter NCC. Sci Adv (2022)
- Release Date
- 2022-11-23
- Peptides
- Solute carrier family 12 member 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.